Company Filing History:
Years Active: 2006-2008
Title: Innovations of J Kendall Killgore in Pharmaceutical Chemistry
Introduction
J Kendall Killgore, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of pharmaceutical chemistry. With a total of three patents to his name, Killgore has developed innovative processes that are pivotal in the synthesis of important pharmaceutical compounds.
Latest Patents
Killgore's latest patents focus on two groundbreaking processes. The first, titled "Process for preparation of (+)-p-mentha-2,8-diene-1-ol," involves a method for preparing this compound by reacting (+)-limonene oxide with amines in the presence of a Lewis acid, leading to amine adducts that are subsequently oxidized and pyrolized to yield the desired product. The second patent, "Methods for the synthesis of alfentanil, sufentanil, and remifentanil," outlines synthetic pathways for creating derivatives or analogs of fentanyl. These methods require fewer steps and have been shown to result in a higher yield of the product compared to previous techniques.
Career Highlights
Currently, Killgore is employed by Mallinckrodt, Inc., where he harnesses his expertise in developing pharmaceutical processes. His inventive work has positioned him as a key figure in advancing methods that enhance production efficiency and product quality.
Collaborations
Throughout his career, Killgore has collaborated with notable colleagues, including Jacob Mathew and Hong Gu. Their partnerships have contributed to the success of several innovative projects within the company, further leveraging their combined expertise in pharmaceutical development.
Conclusion
J Kendall Killgore's inventive contributions to the pharmaceutical industry highlight the importance of innovation in drug synthesis. With his latest patents paving the way for more efficient processes, his work continues to impact the field and inspire future advancements in pharmaceutical chemistry.